Hacksaw has announced the appointment of Ana Vrabic Verdir as permanent CEO, following her role as i...
Following last week's guidance cut and preliminary H1 figures, NFON yesterday released its H1 report...
Redeye comments on Better Collective’s Q2-results which were above our forecast, owing to a slightly...
Q2 figures remain small in absolute terms and do not change our view of the case.
Redeye comments on Cheffelo's Q2 2026 report, showing 24% net sales growth in local currency to SEK3...
Efter storaffären med Nordic Capital och försäljningen av stjärnsegmentet Flow Technology är Cynca N...
Redeye provides an update following Neola Medical’s Q2 2026 report.
Against consensus, EBIT missed in both operating segments and AUM met.
Redeye interviewed Optomed’s CEO, Juho Himberg, following the company’s Q2 2026 report.
Redeye updates its estimates and valuation after Relais’ Q2 2026 report.
SinterCast bekräftar vändningen i volymerna under H1, men vi sänker årets volymantagande 10 procent.
After the readout of ADVANCE in June, which showed a strong tendency towards effect across the two m...
Redeye provides a research update following the Q2 report published by Alzinova earlier today.
The amended European phase Ib/II protocol in myelofibrosis received regulatory clearance and dosed i...
Redeye provides a research update following the Q2 report recently published by ExpreS2ion.
Almonty Industries Inc. is a Montana-based mining company focused on the production and development ...
Q2 contained few surprises, and the small absolute figures remain of limited importance to our estim...
* Sales -SEK 16m, EBITDA -SEK 4.6m vs. ABGSCe * '26e-'28e EBITDA estimates likely down * Share to fo...
* Sales of SEK 89m (+17% vs. ABGSCe 76m), a 63% y-o-y growth * Order book at a record at SEK ~640m *...
* Type A meeting with the FDA scheduled for September 9 * Implementing cost-saving measures * Conf c...